Frankfurt - Delayed Quote EUR

MicroPort CardioFlow Medtech Corporation (72X.F)

0.1010 -0.0020 (-1.94%)
As of 8:01 AM GMT+2. Market Open.
Loading Chart for 72X.F
DELL
  • Previous Close 0.1030
  • Open 0.1010
  • Bid 0.1340 x --
  • Ask 0.1500 x --
  • Day's Range 0.1010 - 0.1010
  • 52 Week Range 0.0645 - 0.2780
  • Volume 200
  • Avg. Volume 3
  • Market Cap (intraday) 336.665M
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, Angelguide tip-preshaped super sti¬ff guidewire, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company also provides technical consultation and technical services for medical devices clinical trial. MicroPort CardioFlow Medtech Corporation was founded in 2010 and is headquartered in Shanghai, China.

www.cardioflowmedtech.com

592

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 72X.F

Performance Overview: 72X.F

Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

72X.F
31.29%
HANG SENG INDEX
11.89%

1-Year Return

72X.F
58.94%
HANG SENG INDEX
2.82%

3-Year Return

72X.F
93.73%
HANG SENG INDEX
31.95%

5-Year Return

72X.F
--
HANG SENG INDEX
34.95%

Compare To: 72X.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 72X.F

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    343.33M

  • Enterprise Value

    215.95M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.65

  • Price/Book (mrq)

    0.83

  • Enterprise Value/Revenue

    5.01

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -140.25%

  • Return on Assets (ttm)

    -9.00%

  • Return on Equity (ttm)

    -18.53%

  • Revenue (ttm)

    336.22M

  • Net Income Avi to Common (ttm)

    -471.53M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.78B

  • Total Debt/Equity (mrq)

    3.02%

  • Levered Free Cash Flow (ttm)

    -251.67M

Research Analysis: 72X.F

Company Insights: 72X.F

Research Reports: 72X.F

People Also Watch